Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

The rise in popularity of DNA tests like 23andMe and AncestryDNA is allowing people to research their family tree with a ...

The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...

Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.

Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...